| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.27B | 23.84B | 23.33B | 18.62B | 14.68B | 16.18B |
| Gross Profit | 2.00B | 1.74B | 2.65B | 2.24B | 1.39B | 2.54B |
| EBITDA | 1.28B | 1.16B | 2.02B | 2.08B | 841.00M | 1.82B |
| Net Income | 397.00M | 200.00M | 986.00M | 1.02B | 138.00M | 932.00M |
Balance Sheet | ||||||
| Total Assets | 63.27B | 64.18B | 58.52B | 50.42B | 48.81B | 43.80B |
| Cash, Cash Equivalents and Short-Term Investments | 6.55B | 6.87B | 3.20B | 8.29B | 11.72B | 10.43B |
| Total Debt | 3.58B | 4.71B | 800.00M | 867.00M | 759.00M | 91.00M |
| Total Liabilities | 19.67B | 20.91B | 13.94B | 12.13B | 11.71B | 7.62B |
| Stockholders Equity | 43.60B | 43.27B | 44.58B | 38.29B | 37.10B | 36.18B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.95B | -6.22B | -3.74B | 497.00M | -1.79B |
| Operating Cash Flow | 0.00 | 3.62B | -4.38B | -1.82B | 1.75B | -1.00B |
| Investing Cash Flow | 0.00 | -2.46B | -388.00M | -292.00M | -1.44B | -638.00M |
| Financing Cash Flow | 0.00 | 2.57B | -304.00M | -325.00M | 442.00M | -234.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥19.63B | 5.93 | ― | 3.03% | 4.18% | 1.38% | |
79 Outperform | ¥117.81B | 10.36 | ― | 3.81% | 0.82% | 30.84% | |
76 Outperform | ¥16.36B | 10.00 | ― | 3.71% | -21.52% | -35.65% | |
70 Outperform | ¥15.87B | 6.90 | ― | 1.39% | 2.98% | 11.88% | |
67 Neutral | ¥15.36B | 4.49 | ― | 3.68% | 5.82% | -22.14% | |
66 Neutral | ¥14.99B | 9.58 | ― | 1.01% | 17.09% | 43.01% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |